Peter Van Vlasselaer

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:3em;padding-top:1em;” typography=”Text {line-height: 30.6px;text-align: center;color: #555555;font-size: 18px;font-weight: 400;}H3 {line-height: 34.2857143px;font-size: 24px;font-weight: 600;text-transform: uppercase;}H1 {line-height: 85.71428574px;text-transform: uppercase;font-size: 60px;font-weight: normal;letter-spacing: 1px;}”]
[background_width][columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″ css_xs=”padding:10px;” css=”padding:1em;”]
[image_scaling css=”background-position:right center;background-repeat:no-repeat;background-size:cover;”]
[image image_style=”imagestyles-23″ image=”https://amphivena.com/wp-content/uploads/2019/07/peter-van-vlasselaer-amphivena.jpg” css_xs=”width:75%;” css=”width:20%;”][/image][/image_scaling]

[text tag=”h4″ typography_xs=”Text {line-height: 34.2857143px;font-size: 24px;}” typography=”Text {line-height: 42.85714287px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 30px;color: #002061;}”]Peter Van Vlasselaer, Ph.D.[/text]

[text tag=”h4″ typography_xs=”Text {line-height: 28.57142858px;font-size: 20px;}” typography=”Text {line-height: 28.57142858px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 20px;}”]Executive Chairman[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/483/images/defaultImage.jpg” css=”padding:20px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css=”width:25%;border-top:1px solid #dddddd;”][/separator]

[text tag=”p” css_xs=”width:100%;” css=”width:70%;display:inline-block;” typography=”Text {line-height: 35px;text-align: justify;}”]Peter has over 20 years of experience in the biotech industry. He was most recently the Founder, President and Chief Executive Officer of ARMO Biosciences, which shortly after its public offering (ARMO) was acquired by Eli Lilly. Before that he was President and Chief Executive Officer of iPierian (acquired by BMS), ARRESTO (acquired by Gilead) and AVIDIA (acquired by AMGEN). In addition to founding ARMO, Dr. Van Vlasselaer was the founder of ARRESTO, co-founder of TrueNorth (acquired by Bioverativ) and he was a member of the start-up teams of InterMune (ITMN) and Dendreon (DNDN). He currently serves on the boards of BLADE Therapeutics, Comet Therapeutics and RGENIX. Dr. Van Vlasselaer has a degree in Zoology and a PhD in Immunology from the Catholic University of Leuven, Belgium. He was a Post-Doctoral Fellow in the Division of Immunology and Rheumatology at Stanford University Medical School and DNAX Research Institute. Dr. Van Vlasselaer has authored several peer reviewed scientific publications and book chapters and he is an inventor on multiple patents.[/text]
[/column]
[/columns][/background_width]
[/section]

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:0em;padding-top:1em;background-color:#ffffff;” typography=”Text {line-height: 27.2px;text-align: center;color: #002061;font-size: 16px;font-weight: 400;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}TextLinkPassive {color: #002061;}TextLinkHovered {color: #0070c0;}H3 {line-height: 34.2857143px;font-size: 24px;font-weight: 600;text-transform: uppercase;color: #002061;}H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}H1 {line-height: 42.85714287px;text-transform: uppercase;font-size: 30px;letter-spacing: 1px;font-style: normal;font-weight: 600;color: #002061;}”]
[columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″]
[text tag=”h1″ typography=”Text {font-weight: normal;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;color: #0070c0;}”]Board of Directors[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/480/images/defaultImage.jpg” css=”padding:10px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css_xs=”width:10%;” line_css=”width:5%;border-top:2px solid #000000;”][/separator]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/peter-van-vlasselaer-bio/” target=”_self” alt=”Peter Van Vlasselaer” image=”https://amphivena.com/wp-content/uploads/2019/07/peter-van-vlasselaer-amphivena.jpg” css_sm=”width:150px;height:150px;” css=”width:180px;height:180px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;margin-top:23px;” typography=”Text {line-height: 22.85714286px;font-size: 16px;font-weight: bold;}”]Peter Van Vlasselaer, Ph.D.[/text]

[text tag=”p” css=”margin-top:0px;”]Executive Chairman[/text]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/eric-moessinger-bio/” target=”_self” alt=”Eric Moessinger” image=”https://amphivena.com/wp-content/uploads/2019/07/eric-moessinger-image.jpg” css_sm=”width:150px;height:150px;” css=”height:180px;width:180px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 28.57142858px;font-size: 20px;font-weight: bold;}”]Eric Moessinger[/text]

[text tag=”p” css=”margin-top:0px;”]NanoDimension[/text]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/mark-mcdade-bio/” target=”_self” alt=”Mark McDade” image=”https://amphivena.com/wp-content/uploads/2019/07/mark-mcdade-amphivena.jpg” css_sm=”width:150px;height:150px;” css=”width:180px;height:180px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 28.57142858px;font-size: 20px;font-weight: bold;}”]Mark McDade[/text]

[text tag=”p” css=”margin-top:0px;”]Qiming Venture Partners USA
[/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em;”]
[image href=”https://amphivena.com/vinay-bhaskar-bio/” target=”_self” alt=”Vinay Bhaskar” image=”https://amphivena.com/wp-content/uploads/amphivena-vinay-bhaskar-ph-d-bio.jpg” css_sm=”width:150px;height:150px;” css=”width:180px;height:180px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 28.57142858px;font-size: 20px;font-weight: bold;}”]Vinay Bhaskar, Ph.D.[/text]

[text tag=”p” css=”margin-top:0px;”]MPM Capital[/text]
[/column]
[/columns]
[/section]

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:0em;padding-top:1em;background-color:#ffffff;” typography=”Text {line-height: 27.2px;text-align: center;color: #002061;font-size: 16px;font-weight: 400;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}TextLinkPassive {color: #002061;}TextLinkHovered {color: #0070c0;}H3 {line-height: 34.2857143px;font-size: 24px;font-weight: 600;text-transform: uppercase;color: #002061;}H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}H1 {line-height: 68.57142859px;text-transform: uppercase;font-size: 48px;letter-spacing: 1px;font-style: normal;font-weight: 600;color: #002061;}”]
[columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_sm=”3″ css=”position:relative;”]

[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/christian-richard-bio/” target=”_self” alt=”Christian Richard” image=”https://amphivena.com/wp-content/uploads/2019/07/christian-richard.jpg” css_sm=”width:150px;height:150px;” css=”width:180px;height:180px;”][/image]

[text tag=”h3″ typography_sm=”Text {line-height: 25.71428572px;font-size: 18px;}” css=”margin-bottom:0px;” typography=”Text {line-height: 28.57142858px;font-size: 20px;font-weight: bold;}”]Christian Richard[/text]

[text tag=”p” css=”margin-top:0px;”]Tekla Capital Management LLC[/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em 0em;”]
[image href=”https://amphivena.com/curtis-l-ruegg-bio/” target=”_self” alt=”Curtis L. Ruegg” image=”https://amphivena.com/wp-content/uploads/amphivena-therapeutics-ceo-curtis-l-ruegg-phd.jpg” css_sm=”width:150px;height:155px;” css=”height:180px;width:180px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 28.57142858px;font-size: 20px;font-weight: bold;}”]Curtis Ruegg, Ph.D.[/text]

[text tag=”p” css=”margin-top:0px;”]CEO & President[/text]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[text tag=”p”][/text]
[/column]
[/columns]
[/section]